Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul:251:239-247.
doi: 10.1016/j.jss.2020.01.028. Epub 2020 Mar 12.

Single-Photon Emission Computed Tomography Imaging Using Formyl Peptide Receptor 1 Ligand Can Diagnose Aortic Aneurysms in a Mouse Model

Affiliations

Single-Photon Emission Computed Tomography Imaging Using Formyl Peptide Receptor 1 Ligand Can Diagnose Aortic Aneurysms in a Mouse Model

Alexander H Shannon et al. J Surg Res. 2020 Jul.

Abstract

Background: Our previous studies showed that neutrophil infiltration and activation plays an important role in the pathogenesis of abdominal aortic aneurysms (AAA). However, there is a lack of noninvasive, inflammatory cell-specific molecular imaging methods to provide early diagnosis of AAA formation. Formyl peptide receptor 1 (FPR1) is rapidly upregulated on neutrophils during inflammation. Therefore, it is hypothesized that the use of cinnamoyl-F-(D)L-F-(D)L-F-K (cFLFLF), a PEGylated peptide ligand that binds FPR1 on activated neutrophils, would permit accurate and noninvasive diagnosis of AAA via single-photon emission computed tomography (SPECT) imaging.

Materials and methods: Male C57BL/6 (wild-type) mice were treated with topical elastase (0.4 U/mL type 1 porcine pancreatic elastase) or heat-inactivated elastase (control), and aortic diameter was measured by video micrometry. Comparative histology was performed on Day 14 to assess neutrophil infiltration in aortic tissue. We performed near-infrared fluorescence imaging using c-FLFLF-Cy7 probe on Days 7 and 14 postelastase treatment and measured fluorescence intensity ex vivo in excised aortic tissue. A separate group of animals were injected with 99mTc-c-FLFLF 2 h before SPECT imaging on Day 14 using a SPECT/computed tomography/positron emission tomography trimodal scanner. Coexpression of neutrophils with c-FLFLF was also performed on aortic tissue by immunostaining on Day 14.

Results: Aortic diameter was significantly increased in the elastase group compared with controls on Days 7 and 14. Simultaneously, a marked increase in neutrophil infiltration and elastin degradation as well as decrease in smooth muscle integrity were observed in aortic tissue after elastase treatment compared with controls. Moreover, a significant increase in fluorescence intensity of c-FLFLF-Cy7 imaging probe was also observed in elastase-treated mice on Day 7 (approximately twofold increase) and Day 14 (approximately 2.5-fold increase) compared with respective controls. SPECT imaging demonstrated a multifold increase in signal intensity for 99mTc-cFLFLF radiolabel probe in mice with AAA compared with controls on Day 14. Immunostaining of aortic tissue with c-FLFLF-Cy5 demonstrated a marked increase in coexpression with neutrophils in AAA compared with controls.

Conclusions: cFLFLF, a novel FPR1 ligand, enables quantifiable, noninvasive diagnosis and progression of AAAs. Clinical application of this inflammatory, cell-specific molecular probe using SPECT imaging may permit early diagnosis of AAA formation, enabling targeted therapeutic interventions and preventing impending aortic rupture.

Keywords: Abdominal aortic aneurysms; Aortic inflammation; Formyl peptide receptor; SPECT scans; Vascular imaging.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Study design and phenotypic data.
(A) The schematic of the elastase treatment murine model of AAA. Infrarenal mouse aortas were treated with elastase or deactivated elastase (Control). Aortic diameter was measured on days 7 or 14, and tissue was harvested for further analysis. SPECT or fluorescence imaging was performed on days 7 and 14. (B) Elastase treated mice demonstrated a significant increase in aortic diameter compared with deactivated elastase treated mice on days 7 and 14, respectively. (C) Representative images of aortic phenotype in all groups. Aortic diameter increased in elastase treated groups compared to control groups. *P<0.0001 vs. Control Day 7; #P<0.0001 vs. Control Day 14; ns, not significant; n=6–15 mice/group.
Figure 2.
Figure 2.. Increased neutrophil infiltration in AAA tissue.
Comparative histology performed on days 7 and 14 indicates that elastase-treated WT mice have a marked increase in neutrophil (PMN) infiltration, a decrease in smooth muscle cell α-actin (SM-αA) expression, as well as increase in elastic fiber disruption (Verhoeff-Van Gieson staining for elastin) compared to deactivated elastase-treated (control) mice, respectively. Quantification of histologic grading indicates a significant increase in neutrophil infiltration, decrease in SM-αA expression and increase in elastic fiber disruption in elastase-treated aortic tissue on days 7 and 14 compared to controls. Arrows indicate areas of immunostaining. *P<0.005 vs. Control Day 7; #P<0.0005 vs. Control Day 14; ns, not significant; n=5 mice/group.
Figure 3.
Figure 3.. Increased uptake of c-FLFLF in AAA by fluorescence imaging of mice.
Near-infrared fluorescence imaging of c-FLFLF-Cy7 in live (shaved) anesthetized mice demonstrating aortic inflammation (elevated fluorescence) at the site of infrarenal AAA formation (see arrows) compared to controls on days 7 (A) and 14 (B). (C) Near-infrared fluorescence imaging of c-FLFLF-Cy7 in ex vivo aortic tissue demonstrating elevated fluorescence compared to controls on day14. (D) Fluorescence intensity (RFU; relative fluorescence units) in ex vivo aortic tissue was significantly increased on day 7 as well as on day 14 in elastase-treated mice (AAA) compared to respective controls. *P<0.05 vs. respective controls; #P<0.05 vs. Elastase Day 7; n=5 mice/group.
Figure 4.
Figure 4.. Increased uptake of c-FLFLF in AAA by SPECT/CT imaging of mice.
(A) SPECT/CT imaging using 99mTc-cFLFLF demonstrated an increase in c-FLFLF uptake (shown by arrows) in elastase-treated mice (AAA) compared to controls on day 14, signifying increased aortic inflammation relative to aneurysms. CT and SPECT scans were utilized to image the animal as it moved along the axis of rotation, allowing for combination of CT and SPECT images using stored offset parameters. (B) A significant increase in 99mTc-cFLFLF radioactivity was observed in harvested aortic tissue from elastase-treated mice compared to controls. *P<0.05 vs. control; n=4–5 mice/group.
Figure 5.
Figure 5.. Co-expression of c-FLFLF with PMNs in AAA tissue.
(A) Immunostaining of murine aortic tissue demonstrates increased c-FLFLF-Cy5 (red) expression in elastase-treated WT mice (bottom panel) compared to controls (top panel) on day 14. A marked increase in neutrophil (Ly6G-FITC; green) expression is also observed in elastase-treated mice compared to control. Moreover, the c-FLFLF expression is co-localized with neutrophils (Ly6G-FITC) indicating the neutrophil-specificity of the c-FLFLF probe. Arrows indicate specific and increased areas of c-FLFLF-Cy5 and Ly6G-FITC expression. (B) Quantification of same normalized areas of imaging demonstrates increased fluorescence intensity of c-FLFLF-Cy5 and Ly6G-FITC. ns, not significant; *P<0.05 vs. respective controls; n=5 mice/group.

Similar articles

Cited by

References

    1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL and Makhoul RG. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000;160:1425–30. - PubMed
    1. Lederle FA, Johnson GR, Wilson SE, Littooy FN, Krupski WC, Bandyk D, Acher CW, Chute EP, Hye RJ, Gordon IL, Freischlag J, Averbook AW and Makaroun MS. Yield of repeated screening for abdominal aortic aneurysm after a 4-year interval. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000;160:1117–21. - PubMed
    1. Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, Parsons RW and Dickinson JA. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329:1259. - PMC - PubMed
    1. Cosford PA and Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev. 2007:CD002945. - PubMed
    1. Brewster DC, Cronenwett JL, Hallett JW Jr., Johnston KW, Krupski WC, Matsumura JS, Joint Council of the American Association for Vascular S and Society for Vascular S. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg. 2003;37:1106–17. - PubMed

Publication types